Obstetrics

A new artificial intelligence-based study found risk factor combinations linked to severe adverse pregnancy outcomes, offering a more personalized and transparent approach to risk assessment in obstetrics.

Prediction models for severe preeclampsia complications are most accurate on day 2 after hospital admission but become less reliable over time, according to a recent study.

Fetal ventriculomegaly, a condition marked by the dilation of cerebral ventricles, is a common finding on second-trimester ultrasounds and requires careful evaluation to determine its causes, severity, and potential impact on neurological outcomes.

A recent study highlights the need to manage chronic hypertension before and during pregnancy to mitigate the heightened risk of severe maternal morbidity associated with preeclampsia.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The Rural Obstetrics Readiness Act aims to enhance maternal health in rural communities by providing federal grants, training programs, and telehealth services to better manage obstetric emergencies.

A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.

Discover how Mirvie’s RNA platform uses a simple blood test to detect fetal growth restriction early in pregnancy, allowing for proactive interventions and improved outcomes for mothers and babies.

Learn how carrier screening and noninvasive prenatal testing help expectant parents identify genetic risks early, explore reproductive options, and prepare for the best possible pregnancy outcomes.

Nicola F. Tavella, MPH, dives into his team's research on postpartum depression and unplanned cesarean delivery, which was presented at SMFM's 2025 Pregnancy Meeting.

Discover the latest advancements in prenatal genetic screening, the challenges preventing access, and how increased awareness can help expecting parents make informed decisions.

Discover how maternal fetal medicine specialists are tackling maternal mortality disparities through trust-building, diverse care teams, and comprehensive support programs.

Timely diagnosis of gestational diabetes is crucial for optimal maternal and fetal health, but a recent study highlights demographic disparities in screening delays and the need for further research on potential health impacts.

A new study links first-trimester hemorrhage and anemia to a higher placenta accreta spectrum risk, emphasizing early screening and non-traditional risk factors.

AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.

Daniel L. Kuhr, MD, maternal fetal medicine fellow at Mount Sinai, discusses the role of neighborhood-level indices in predicting spontaneous preterm birth risk and why individual patient characteristics remain the key factor.

Researchers have identified higher concentrations of microplastics and nanoplastics in the placentae of infants born prematurely compared to those born at term, a new study finds.

A new study presented at the SMFM 2025 Pregnancy Meeting found that homicide and suicide are the leading causes of maternal death in the United States.

A new study explores the potential link between antiretroviral therapy, specifically integrase inhibitors, and fetal biometric measurements, shedding light on possible pregnancy complications.

Artificial intelligence-powered ultrasound analysis is enhancing the early detection of congenital heart defects, improving diagnostic accuracy, physician confidence, and neonatal outcomes.

The Mothers and Newborns affected by Opioids - Obstetric initiative significantly increased screening, treatment access, and naloxone counseling for pregnant patients with opioid use disorder, enhancing care and reducing racial disparities.

A recent study found insufficient evidence that oral furosemide reduces the risk of de novo postpartum hypertension, highlighting the need for close monitoring in the first 2 weeks after birth.

A study highlights chronic villitis as a specific placental injury associated with COVID-19, raising concerns about pregnancy complications such as preeclampsia and stillbirth.

Dr. Ulla-Britt Wennerholm explores the risks and benefits of induction for prolonged pregnancies, highlighting new research on optimal gestational age and outpatient induction trials.

A recent study highlights lasting platelet hyperreactivity in women with gestational diabetes mellitus, suggesting it could serve as a therapeutic target to mitigate long-term complications.